Synnovation Therapeutics
PrivateLast Round
Series A
Jan 24, 2024
Total Funding Raised
$147M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Synnovation Therapeutics is a biotechnology company that develops precision small molecule therapies for the treatment of cancer and immunological diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synnovation Therapeutics Comparables
Compare Synnovation Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Duke Street Bio | 89% | |
| 1cBio, Inc. | 87% | |
| Idience Co., Ltd. | 83% | |
Synnovation Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 24, 2024 | ||||
| Series A | May 24, 2023 | ||||
| Seed | Nov 24, 2021 |
Synnovation Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sirona Capital | Series A |
| Cormorant Asset Management | Series A |
| Lilly Asia Ventures | Series A |
| Nextech Invest | Series A |
| Lilly Asia Ventures | Series A |
| Cormorant Asset Management | Series A |
| Third Rock Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 28, 2026
Acquired Excellergy Inc. for $2 billion.
- Mar 20, 2026
Novartis acquired PI3Kα inhibitor program for $3 billion.
Synnovation Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Synnovation Therapeutics's valuation, stock price, and market status.